meta|evidence COVID-19
  • Living systematic review and meta-analysis
  • adjuvant therapies
  • anti-inflammatoty and immuno-therapy
  • antiandrogenic
  • antiviral and associated therapy
  • control
  • Drugs for acid related disorders
  • miscellaneous
  • Oral antidiabetic drugs
  • Renin-angiotensin-system-acting agents
  • vaccines
  • A EFFACER BBV152 (Bharat Biotech, India)
  • A EFFACER Janssen Ad.26.COV2.S vaccine (JNJ-78436725)
  • A EFFACER_ Vero cell
  • A EFFACER_sequential Immunization
  • BCG vaccination
  • complete primary vaccine series
  • CoVLP (MT-2766, Medicago)
  • DNA vaccine
  • bacTRL-Spike
  • Zy-Cov-D (Zydus Cadila)
  • ebola vaccine
  • first booster dose
  • mRNA vaccine (any) - first boost
  • Comirnaty - first boost
  • Spikevax - first boost
  • Non replicating viral vector -first boost
  • Janssen AD26 vaccine - fisrt boost
  • Vaxzevria -first boost
  • heterologous prime-boost
  • Inactivated virus vaccine
  • CoronaVac (SinoVac)
  • Covaxin, Bharat Biotech (BBV152)
  • Shifa-Pharmed inactivated vaccine
  • Sinopharm Beijing (BBIBP-CorV)
  • Sinopharm Wuhan
  • mRNA vaccine
  • Comirnaty (tozinameran - Pfizer/BIONTECH)
  • CureVac
  • Spikevax (Moderna mRNA-1273 COVID-19 vaccine)
  • Non replicating viral vector
  • Ad26.RSV.preF (respiratory syncytial virus)
  • Ad26.ZEBOV ()
  • Ad26.ZIKV.001 (Ad26-Vectored Anti-Zika Virus Vaccine)
  • CanSino (Convidecia)
  • Covishield (Oxford/AZ formulation)
  • Janssen AD26 vaccine (JNJ-78436735)
  • Sputnik V (Gam-COVID-Vac)
  • SPUTNIK-LIGHT
  • Vaxzevria (AstraZeneca Oxford - ChAdOx1 nCoV-19)
  • protein subunit vaccine
  • Anhui Zhifei Longcom
  • CoVax-19 SpikoGen
  • Nuvaxovid (NVX-CoV2373) Novavax
  • Sanofi/GSK recombinant protein vaccine
  • SCB-2019
  • Replicating Viral Vector
  • seasonal influenza vaccines
  • second booster dose
  • mRNA vaccine (any) - second boost
  • Comirnaty - second boost
  • Spikevax - second boost
  • virus-like particles vaccine
  • Medicago
  • Vitamins
  • COVID 19 hospitalized
  • COVID 19 all comers
  • COVID-19 mild to moderate
  • COVID-19 severe or critically
  • COVID 19 outpatients
  • COVID-19 (hospitalized or not)
  • COVID-19 prophylaxis (children)
  • COVID-19 prophylaxis (excluding children)
  • infections other than COVID-19
  • Long COVID-19
  • preventing respiratory virus transmission
  • secondary prevention